23 May 2013
Keywords: fda, oks, ixempra, breast, cancer, drug, major
Article | 22 October 2007
US drug major Bristol-Myers Squibb says that the US Food and Drug Administration has approved its drug Ixempra (ixabepilone) as ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 October 2007
22 May 2013
© 2013 thepharmaletter.com